北大医药涨2.14%，成交额8722.37万元，主力资金净流入43.30万元

Group 1 - The core viewpoint of the news is that Beida Pharmaceutical has shown a positive stock performance with a 9.33% increase in stock price since the beginning of the year and a market capitalization of 3.981 billion yuan [1] - As of January 13, the stock price reached 6.68 yuan per share, with a trading volume of 87.22 million yuan and a turnover rate of 2.21% [1] - The company has a diverse revenue structure, with 34.69% from pharmaceuticals, 34.34% from formulation drugs, 30.82% from medical devices and reagents, and minimal contributions from other sales [1] Group 2 - As of September 30, the number of shareholders decreased by 2.88% to 49,400, while the average circulating shares per person increased by 2.97% to 12,073 shares [2] - For the period from January to September 2025, Beida Pharmaceutical reported a revenue of 1.231 billion yuan, a year-on-year decrease of 19.76%, while the net profit attributable to shareholders increased by 4.31% to 136 million yuan [2] - The company has distributed a total of 183 million yuan in dividends since its A-share listing, with 81.05 million yuan distributed in the last three years [3]